skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Results 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The use of umbilical cord#8208;derived mesenchymal stem cells in patients with muscular dystrophies: Results from compassionate use in real#8208;life settings
Material Type:
Article
Add to My Research

The use of umbilical cord#8208;derived mesenchymal stem cells in patients with muscular dystrophies: Results from compassionate use in real#8208;life settings

Stem cells translational medicine, 2021-10, Vol.10 (10), p.1372 [Peer Reviewed Journal]

COPYRIGHT 2021 Oxford University Press ;ISSN: 2157-6580 ;EISSN: 2157-6580 ;DOI: 10.1002/sctm.21-0027

Full text available

2
Age‐Dependent Effect of Pediatric Cardiac Progenitor Cells After Juvenile Heart Failure
Material Type:
Article
Add to My Research

Age‐Dependent Effect of Pediatric Cardiac Progenitor Cells After Juvenile Heart Failure

Stem cells translational medicine, 2016-07, Vol.5 (7), p.883-892 [Peer Reviewed Journal]

2016 AlphaMed Press ;AlphaMed Press. ;Copyright John Wiley & Sons, Inc. Jul 2016 ;AlphaMed Press 2016 ;ISSN: 2157-6564 ;EISSN: 2157-6580 ;DOI: 10.5966/sctm.2015-0241 ;PMID: 27151913

Full text available

3
Report of a Phase II Study of Clofarabine and Cytarabine in De Novo and Relapsed and Refractory AML Patients and in Selected Elderly Patients at High Risk for Anthracycline Toxicity
Material Type:
Article
Add to My Research

Report of a Phase II Study of Clofarabine and Cytarabine in De Novo and Relapsed and Refractory AML Patients and in Selected Elderly Patients at High Risk for Anthracycline Toxicity

The oncologist (Dayton, Ohio), 2011-02, Vol.16 (2), p.197-206 [Peer Reviewed Journal]

2011 AlphaMed Press ;AlphaMed Press 2011 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2010-0220 ;PMID: 21273514

Full text available

4
A Detailed Assessment of Varying Ejection Rate on Delivery Efficiency of Mesenchymal Stem Cells Using Narrow‐Bore Needles
Material Type:
Article
Add to My Research

A Detailed Assessment of Varying Ejection Rate on Delivery Efficiency of Mesenchymal Stem Cells Using Narrow‐Bore Needles

Stem cells translational medicine, 2016-03, Vol.5 (3), p.366-378 [Peer Reviewed Journal]

2016 AlphaMed Press ;AlphaMed Press. ;Copyright John Wiley & Sons, Inc. Mar 2016 ;AlphaMed Press 2016 ;ISSN: 2157-6564 ;EISSN: 2157-6580 ;DOI: 10.5966/sctm.2015-0208 ;PMID: 26826162

Full text available

5
Secretome signature of cardiopoietic cells echoed in rescued infarcted heart proteome
Material Type:
Article
Add to My Research

Secretome signature of cardiopoietic cells echoed in rescued infarcted heart proteome

Stem cells translational medicine, 2021-09, Vol.10 (9), p.1320-1328 [Peer Reviewed Journal]

2021 The Authors. published by Wiley Periodicals LLC on behalf of AlphaMed Press. ;2021 The Authors. STEM CELLS TRANSLATIONAL MEDICINE published by Wiley Periodicals LLC on behalf of AlphaMed Press. ;2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2157-6564 ;EISSN: 2157-6580 ;DOI: 10.1002/sctm.20-0509 ;PMID: 34047493

Full text available

6
Association Between Skin Reaction and Clinical Benefit in Patients Treated with Anti‐Programmed Cell Death 1 Monotherapy for Advanced Non‐Small Cell Lung Cancer
Material Type:
Article
Add to My Research

Association Between Skin Reaction and Clinical Benefit in Patients Treated with Anti‐Programmed Cell Death 1 Monotherapy for Advanced Non‐Small Cell Lung Cancer

The oncologist (Dayton, Ohio), 2020-03, Vol.25 (3), p.e536-e544 [Peer Reviewed Journal]

AlphaMed Press 2019 ;AlphaMed Press 2019. ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2019-0550 ;PMID: 32162801

Full text available

7
Transforming the Approach to Cell‐Based Therapies
Material Type:
Article
Add to My Research

Transforming the Approach to Cell‐Based Therapies

Stem cells translational medicine, 2017-05, Vol.6 (5), p.1305-1306 [Peer Reviewed Journal]

2017 The Authors published by Wiley Periodicals, Inc. on behalf of AlphaMed Press ;COPYRIGHT 2017 Oxford University Press ;2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2017 The Authors S C T M published by Wiley Periodicals, Inc. on behalf of AlphaMed Press ;ISSN: 2157-6564 ;ISSN: 2157-6580 ;EISSN: 2157-6580 ;DOI: 10.1002/sctm.17-0064 ;PMID: 28456006

Full text available

8
A preview of selected articles
Material Type:
Article
Add to My Research

A preview of selected articles

Stem cells translational medicine, 2020-10, Vol.9 (10), p.1115-1117 [Peer Reviewed Journal]

2020 The Author. published by Wiley Periodicals LLC on behalf of AlphaMed Press ;2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2157-6564 ;EISSN: 2157-6580 ;DOI: 10.1002/sctm.20-0395

Full text available

9
Human mesenchymal stromal cells do not express ACE2 and TMPRSS2 and are not permissive to SARS‐CoV‐2 infection
Material Type:
Article
Add to My Research

Human mesenchymal stromal cells do not express ACE2 and TMPRSS2 and are not permissive to SARS‐CoV‐2 infection

STEM CELLS Translational Medicine, 2021-04, Vol.10 (4), p.636-642 [Peer Reviewed Journal]

2020 The Authors. published by Wiley Periodicals LLC on behalf of AlphaMed Press. ;2020 The Authors. STEM CELLS TRANSLATIONAL MEDICINE published by Wiley Periodicals LLC on behalf of AlphaMed Press. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2157-6564 ;EISSN: 2157-6580 ;DOI: 10.1002/sctm.20-0385 ;PMID: 33188579

Digital Resources/Online E-Resources

10
Management of Cancer in the Older Person: A Practical Approach
Material Type:
Article
Add to My Research

Management of Cancer in the Older Person: A Practical Approach

The oncologist (Dayton, Ohio), 2000-06, Vol.5 (3), p.224-237 [Peer Reviewed Journal]

2000 AlphaMed Press ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.5-3-224 ;PMID: 10884501

Full text available

11
Umbilical Cord Blood Transplantation: Challenges and Future Directions
Material Type:
Article
Add to My Research

Umbilical Cord Blood Transplantation: Challenges and Future Directions

Stem cells translational medicine, 2017-05, Vol.6 (5), p.1312-1315 [Peer Reviewed Journal]

2017 The Authors published by Wiley Periodicals, Inc. on behalf of AlphaMed Press ;2017 The Authors Stem Cells Translational Medicine published by Wiley Periodicals, Inc. on behalf of AlphaMed Press. ;COPYRIGHT 2017 Oxford University Press ;2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2017 The Authors S C T M published by Wiley Periodicals, Inc. on behalf of AlphaMed Press ;ISSN: 2157-6564 ;ISSN: 2157-6580 ;EISSN: 2157-6580 ;DOI: 10.1002/sctm.17-0069 ;PMID: 28456009

Full text available

12
Clinical Practices and Institutional Protocols on Prophylaxis, Monitoring, and Management of Selected Adverse Events Associated with Trastuzumab Deruxtecan
Material Type:
Article
Add to My Research

Clinical Practices and Institutional Protocols on Prophylaxis, Monitoring, and Management of Selected Adverse Events Associated with Trastuzumab Deruxtecan

The oncologist (Dayton, Ohio), 2022-08, Vol.27 (8), p.637-645 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press. ;COPYRIGHT 2022 Oxford University Press ;The Author(s) 2022. Published by Oxford University Press. 2022 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyac107 ;PMID: 35642907

Full text available

13
Adjuvant Trastuzumab Therapy: Can We Balance Efficacy and Safety?
Material Type:
Article
Add to My Research

Adjuvant Trastuzumab Therapy: Can We Balance Efficacy and Safety?

The oncologist (Dayton, Ohio), 2019-11, Vol.24 (11), p.1405-1409 [Peer Reviewed Journal]

AlphaMed Press 2019 ;AlphaMed Press 2019. ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2019-0263 ;PMID: 31315962

Full text available

14
Functional Impairment of Human Resident Cardiac Stem Cells by the Cardiotoxic Antineoplastic Agent Trastuzumab
Material Type:
Article
Add to My Research

Functional Impairment of Human Resident Cardiac Stem Cells by the Cardiotoxic Antineoplastic Agent Trastuzumab

Stem cells translational medicine, 2012-04, Vol.1 (4), p.289-297 [Peer Reviewed Journal]

2012 AlphaMed Press ;Copyright John Wiley & Sons, Inc. Apr 2012 ;AlphaMed Press 1066-5099/2012/$20.00/0 2012 ;ISSN: 2157-6564 ;EISSN: 2157-6580 ;DOI: 10.5966/sctm.2011-0016 ;PMID: 23197808

Full text available

15
Abstract 23 HLA-Homozygous iPSC from Cord Blood for the Generation of Cardiomyocytes for Allogeneic Cell Therapy to the Heart
Material Type:
Article
Add to My Research

Abstract 23 HLA-Homozygous iPSC from Cord Blood for the Generation of Cardiomyocytes for Allogeneic Cell Therapy to the Heart

Stem cells translational medicine, 2023-09, Vol.12 (Supplement_1), p.S25-S25 [Peer Reviewed Journal]

The Author(s) 2023. Published by Oxford University Press. 2023 ;ISSN: 2157-6564 ;EISSN: 2157-6580 ;DOI: 10.1093/stcltm/szad047.024

Full text available

16
Ewing's Sarcoma Family of Tumors: Current Management
Material Type:
Article
Add to My Research

Ewing's Sarcoma Family of Tumors: Current Management

The oncologist (Dayton, Ohio), 2006-05, Vol.11 (5), p.503-519 [Peer Reviewed Journal]

2006 AlphaMed Press ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.11-5-503 ;PMID: 16720851

Full text available

17
Concise Review: Mesoangioblast and Mesenchymal Stem Cell Therapy for Muscular Dystrophy: Progress, Challenges, and Future Directions
Material Type:
Article
Add to My Research

Concise Review: Mesoangioblast and Mesenchymal Stem Cell Therapy for Muscular Dystrophy: Progress, Challenges, and Future Directions

Stem cells translational medicine, 2015-01, Vol.4 (1), p.91-98 [Peer Reviewed Journal]

2015 AlphaMed Press ;AlphaMed Press. ;Copyright John Wiley & Sons, Inc. Jan 2015 ;AlphaMed Press 2015 ;ISSN: 2157-6564 ;EISSN: 2157-6580 ;DOI: 10.5966/sctm.2014-0060 ;PMID: 25391645

Full text available

18
Nestin Expression in End‐Stage Disease in Dystrophin‐Deficient Heart: Implications for Regeneration From Endogenous Cardiac Stem Cells
Material Type:
Article
Add to My Research

Nestin Expression in End‐Stage Disease in Dystrophin‐Deficient Heart: Implications for Regeneration From Endogenous Cardiac Stem Cells

Stem cells translational medicine, 2013-11, Vol.2 (11), p.848-861 [Peer Reviewed Journal]

2013 AlphaMed Press ;Copyright John Wiley & Sons, Inc. Nov 2013 ;AlphaMed Press 1066-5099/2013/$20.00/0 2013 ;ISSN: 2157-6564 ;EISSN: 2157-6580 ;DOI: 10.5966/sctm.2012-0174 ;PMID: 24068741

Full text available

19
Effects of Transendocardial CD34+ Cell Transplantation on Diastolic Parameters in Patients with Nonischemic Dilated Cardiomyopathy
Material Type:
Article
Add to My Research

Effects of Transendocardial CD34+ Cell Transplantation on Diastolic Parameters in Patients with Nonischemic Dilated Cardiomyopathy

Stem cells translational medicine, 2017-06, Vol.6 (6), p.1515-1521 [Peer Reviewed Journal]

2017 The Authors published by Wiley Periodicals, Inc. on behalf of AlphaMed Press ;2017 The Authors Stem Cells Translational Medicine published by Wiley Periodicals, Inc. on behalf of AlphaMed Press. ;COPYRIGHT 2017 Oxford University Press ;2017. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2017 The Authors S C T M published by Wiley Periodicals, Inc. on behalf of AlphaMed Press ;ISSN: 2157-6564 ;ISSN: 2157-6580 ;EISSN: 2157-6580 ;DOI: 10.1002/sctm.16-0331 ;PMID: 28296283

Full text available

20
Vascular Smooth Muscle Cells From Hypertensive Patient‐Derived Induced Pluripotent Stem Cells to Advance Hypertension Pharmacogenomics
Material Type:
Article
Add to My Research

Vascular Smooth Muscle Cells From Hypertensive Patient‐Derived Induced Pluripotent Stem Cells to Advance Hypertension Pharmacogenomics

Stem cells translational medicine, 2015-12, Vol.4 (12), p.1380-1390 [Peer Reviewed Journal]

2015 AlphaMed Press ;AlphaMed Press. ;Copyright John Wiley & Sons, Inc. Dec 2015 ;AlphaMed Press 2015 ;ISSN: 2157-6564 ;EISSN: 2157-6580 ;DOI: 10.5966/sctm.2015-0126 ;PMID: 26494780

Full text available

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2003  (10)
  2. 2003 To 2007  (20)
  3. 2008 To 2012  (42)
  4. 2013 To 2018  (117)
  5. After 2018  (77)
  6. More options open sub menu

Searching Remote Databases, Please Wait